ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Cadaveric organs"

  • 2016 American Transplant Congress

    Outcomes in Black vs Non-Black Patients Administered Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.

    S. Florman,1 A. Durrbach,2 V. Duro Garcia,3 K. Calderon,4 U. Meier-Kriesche,4 M. Polinsky,4 H. Zhao,4 J. Medina Pestana.5

    1Mount Sinai Med Ctr, New York; 2Univ Hôpital of Bicêtre, Le Kremlin-Bicêtre, France; 3Hosp Dom Vicente Scherer, Porto Alegre, Brazil; 4BMS, Lawrenceville; 5Hosp do Rim, Sao Paulo, Brazil.

    Studies consistently show worse outcomes for black vs non-black kidney transplant recipients. At 7 yrs post-transplant in BENEFIT-EXT (NCT00114777), bela was associated with similar graft…
  • 2016 American Transplant Congress

    Missed Opportunities After Cardiac Death: Should Every Donation After Cardiac Death (DCD) Referral Be Pursued? A Large Single US Organ Procurement Organization (OPO) Experience.

    S. Rudich, R. Messer, R. Pietroski, P. Lange.

    Medical Division, Gift of Life Michigan, Ann Arbor, MI.

    We wished to evaluate in detail those DCD cases in which our OPO did not pursue organ donation but the potential DCD candidate expired within…
  • 2016 American Transplant Congress

    Long-Term Outcomes in Epstein-Barr Virus (EBV)-Positive Patients Receiving Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.

    S. Florman,1 J. Medina Pestana,2 M. del C Rial,3 L. Rostaing,4 D. Kuypers,5 A. Matas,6 T. Wekerle,7 J. Grinyó,8 U. Meier-Kriesche,9 M. Polinsky,9 H. Zhao,9 A. Durrbach.10

    1Mount Sinai Med Ctr, New York; 2Hosp do Rim, Sao Paulo, Brazil; 3Instituto de Nefrologia, Buenos Aires, Argentina; 4Univ Hosp, Toulouse, France; 5Univ Hosp Leuven, Leuven, Belgium; 6Univ of Minnesota, Minneaopolis; 7Med Univ of Vienna, Vienna, Austria; 8Univ Hosp Bellvitge, Barcelona, Spain; 9BMS, Lawrenceville; 10Univ Hôpital of Bicêtre, Le Kremlin-Bicêtre, France.

    At 7 yrs post transplant in BENEFIT-EXT (NCT00114777), bela-treated pts had similar graft survival and improved renal function vs CsA-treated pts. Bela is indicated for…
  • 2016 American Transplant Congress

    The Immunologic Profile of Brain Death in Humans: A Whole-Body Analysis.

    D. Carpenter,1,2 N. Matsuoka,1 J. Thome,1,3 T. Granot,1,3 C. Gordon,1,3 B. Kumar,1,3 T. Senda,1,3 M. Miron,1,3 J. Weiner,2 A. Griesemer,1,2 D. Farber.1,2,3

    1Columbia Center for Translational Immunology, Columbia University Medical Center, New York City, NY; 2Surgery, Columbia University Medical Center, New York City, NY; 3Microbiology and Immunology, Columbia University Medical Center, New York City, NY.

    Transplantation outcomes are believed to be influenced by a generalized inflammatory state caused by brain death itself or events in the peri-transplant period. Studies on…
  • 2016 American Transplant Congress

    Impact of the Kidney Allocation System with Deceased Donor Kidney Utilization at the DSA Level.

    W. Ally,2 C. Saunders,1 K. Brayman,2 A. Agarwal.2

    1Lifenet Health, Virginia Beach, VA; 2University of Virginia Health System, Charlottesville, VA.

    Background: In December 2014, UNOS implemented broad sweeping changes in the new Kidney Allocation System (KAS). Recent summary reports by UNOS suggest that on a…
  • 2016 American Transplant Congress

    Multiorgan Procurement a Learning Tool in General Surgical Resident Education.

    J. Bayer, R. Goldstein, G. McKenna, G. Testa, R. Ruiz, T. Anthony, N. Onaca, G. Klintmalm, P. Kim.

    Transplant Surgery, Baylor University Medical Center, Dallas, TX.

    IntroductionRestricted duty hours and the growing use of minimally invasive techniques, is limiting the open surgical experience for general surgery (GS) residents. Multiorgan procurement (MP)…
  • 2016 American Transplant Congress

    Donors with Isolated Anti-HBc (“HBcAb Only”) Antibodies: True Evidence for Past Infection or Laboratory Artifact? Toward a Simple Confirmatory Test for HBcAb.

    Y. Chang,1,3 C. Chinchilla-Reyes,2 M. Koss,1,2 M. Nowicki.1,2

    1Mendez National Institute of Transplantation Foundation, Los Angeles, CA; 2Viracor-IBT Laboratories, Los Angeles, CA; 3Western University of Health Sciences, Pomona, CA.

    Use of organs from donors positive for hepatitis B virus (HBV) markers may safely expand the donor pool. Recently the American Society of Transplantation expert…
  • 2016 American Transplant Congress

    Steroid Free Immunosuppression and Clinical Outcomes in Recipients of Deceased Donor Kidney Transplant with Positive Flow Cytometry Crossmatch.

    O. Adebiyi, T. Taber, W. Goggins, D. Mishler, M. Yaqub, A. Sharfuddin.

    Indiana University, Indianapolis.

    Background: Positive flow cytometry crossmatch (FCXM) is considered a high immunologic risk for transplantation. Available studies reporting outcomes in positive FCXM kidney transplants were done…
  • 2016 American Transplant Congress

    Utilization of HCV-Positive Donors' Kidneys: Potential Benefits in the Era of Direct Acting Antiviral (DAA) Therapy.

    B. Amundsen,1 M. Sise,2 M. Lin,3 H. Deirawan,1 E. Heher,2 B. Kimball,1 J. Markmann,1 N. Elias.1

    1Massachusetts General Hospital, Boston, MA; 2Massachusetts General Hospital, Boston, MA; 3Brigham and Women's Hospital, Boston, MA.

    Organ shortage and expanding kidney waiting list fostered utilization of HCV positive donors' organs (HCVD+). HCVD+ kidneys have slightly worse long term outcomes compared with…
  • 2016 American Transplant Congress

    Comparing Renal Function After Liver Transplantation: Modified Piggyback versus Conventional Techniques without Venovenous Bypass.

    J. Lee, J. Lee, S. Song, J. Lee, S.-K. Kwon, D. Han, M. Ju, G. Choi, J. Choi, M. Kim, S. Kim, D. Joo.

    Surgery, Yonsei University College of Medicine, Seoul, Korea.

    BackgroundThere are several options available for caval reconstruction in liver transplantation. Prior reports demonstrated that caval reconstruction technique could affect the renal function. However, there…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences